Can You Have a Baby With Glanzmann Thrombasthenia?
At a Glance
Yes, women with Glanzmann Thrombasthenia can have a baby, but the pregnancy is high-risk. Safe delivery requires a highly specialized medical team to manage severe bleeding risks like postpartum hemorrhage and to protect the baby from platelet complications.
In this answer
7 sections
Yes, it is possible for women with Glanzmann Thrombasthenia (GT) to have a baby, but the pregnancy must be treated as high-risk and requires meticulous planning [1][2]. Because your platelets do not function properly, the natural tissue trauma of childbirth and the detachment of the placenta pose a significant risk of severe bleeding, particularly after the baby is born [1][3]. Additionally, if your immune system has developed antibodies against normal platelets, these can cross the placenta and affect your baby’s platelet levels [4]. While reading about these risks can be frightening, a successful pregnancy with GT is absolutely possible. It depends entirely on assembling a highly specialized medical team to monitor you closely and manage these risks before, during, and after delivery [5][6].
Building Your Specialized Care Team
Because GT is rare, standard obstetrical care is not enough. Managing pregnancy and delivery requires a coordinated, multidisciplinary approach [5][7]. Your hematologist and high-risk obstetrician will typically act as the “quarterbacks” of your care team, coordinating all other specialists. Your team should ideally include:
- A High-Risk Obstetrician (Maternal-Fetal Medicine Specialist) to monitor the pregnancy and plan a safe delivery.
- A Hematologist who specializes in bleeding disorders to manage your platelet levels and blood clotting medications.
- An Obstetric Anesthesiologist to evaluate pain management options and the risks of specific procedures [5][6][2].
- A Neonatologist ready to evaluate and treat the newborn immediately after birth for any bleeding or platelet issues.
It is highly recommended that you deliver at a specialized tertiary care center that has a high-level Neonatal Intensive Care Unit (NICU) and 24/7 access to a specialized hematology laboratory and necessary blood products [8][4].
Monitoring During the 9 Months of Pregnancy
Throughout your pregnancy, your team will monitor you closely for any signs of bleeding. Because of your GT, early pregnancy complications—such as spotting or the tragic event of a miscarriage—carry a higher risk of significant bleeding and may require emergency medical intervention with medications or blood products [1][2]. You will need a clear emergency plan detailing exactly where to go and who to call if you experience any bleeding during the nine months.
Choosing the Safest Delivery Method
When planning for childbirth, a vaginal delivery is generally preferred over a planned Cesarean section (C-section) [5][3]. This is because a C-section is a major surgery that involves significant incisions, which creates more tissue damage and a higher risk of surgical bleeding for someone with GT. C-sections are typically reserved for situations where they are medically necessary for standard obstetric reasons (like the baby’s position or heart rate).
The Primary Risk: Postpartum Hemorrhage
The most significant danger during childbirth for someone with GT is postpartum hemorrhage (PPH), which is severe bleeding after the baby is delivered [1][2][3]. To prevent and treat PPH, your team will likely use specific medications and therapies during and immediately after delivery:
- Platelet Transfusions: Often a primary treatment to help your blood clot. However, their effectiveness can be limited if you have developed antibodies from past blood transfusions, prior pregnancies, or even miscarriages [9][2].
- Recombinant Activated Factor VII (rFVIIa): This is a medication that helps blood clot by bypassing the need for properly functioning platelets. It is an effective option for preventing and treating bleeding during delivery, especially for patients who do not respond well to platelet transfusions [10][9][11].
- Antifibrinolytics: Medications (like tranexamic acid) that help prevent blood clots from breaking down. These are often used alongside platelets or rFVIIa [12][13].
During delivery, your doctors may use specialized blood tests (like thromboelastography) to constantly check how well your blood is clotting and guide your treatment in real-time [8].
Pain Management and Anesthesia Risks
One of the most critical decisions for delivery with GT is pain management. Neuraxial anesthesia—which includes epidurals and spinal blocks—carries a significant risk of causing a spinal epidural hematoma (bleeding around the spinal cord) in people with severe bleeding disorders [3][14]. Because of this severe risk, epidurals are frequently not recommended [15][8]. You and your anesthesiologist must carefully discuss alternative pain management strategies for a vaginal birth, as well as general anesthesia options if a C-section becomes necessary [3].
Protecting the Baby: The Risk of NAIT
During pregnancy, your body may recognize your baby’s normal platelets as “foreign” because they possess proteins (integrins) that your GT platelets lack [4][16]. This can cause your immune system to produce antibodies that cross the placenta and destroy the baby’s platelets, a condition known as Neonatal Alloimmune Thrombocytopenia (NAIT) [4].
If your baby develops NAIT, they could be born with severely low platelets and a high risk of bleeding, including bleeding in the brain [4][17]. To manage this risk:
- You will need regular blood tests to check if your body is making antibodies against normal platelets (a process sometimes called alloimmunization) before and during pregnancy [5][9][4].
- If antibodies are detected, your doctor may recommend treatments during pregnancy, such as intravenous immunoglobulins (IVIG), to help protect the baby [4].
- After birth, the newborn’s platelet levels must be checked immediately. If they are dangerously low, the baby may need specialized platelet transfusions or IVIG [18][19].
Preparing for Pregnancy
Because of these complexities, preparation should begin long before you become pregnant. Preconception counseling with your hematologist and a high-risk obstetrician is essential [5][20]. You should also consider genetic counseling to understand the likelihood of passing the GT gene to your child and to discuss options like prenatal diagnosis or preimplantation genetic testing [21][22].
Common questions in this guide
Is it safe to get an epidural if I have Glanzmann Thrombasthenia?
Can I deliver vaginally with Glanzmann Thrombasthenia?
What is the biggest risk during childbirth for someone with GT?
How does Glanzmann Thrombasthenia affect my baby?
What kind of doctors do I need if I am pregnant and have GT?
Questions for Your Doctor
6 questions
- •What specific blood tests do we need to run before I try to get pregnant to check if my body has developed antibodies against normal platelets?
- •Does this hospital keep recombinant Factor VIIa (rFVIIa) stocked in the pharmacy 24/7 for my delivery?
- •Since an epidural may not be safe for me, what are the exact alternative pain management plans for a vaginal delivery or a C-section?
- •Who will act as the 'quarterback' coordinating between my hematologist, maternal-fetal medicine specialist, and anesthesiologist?
- •What is the emergency plan and where should I go if I start experiencing spotting or bleeding during my first or second trimester?
- •What is the precise protocol for evaluating and protecting my baby from NAIT immediately after they are born?
Questions for You
4 questions
- •Have I required blood or platelet transfusions in the past, or have I had previous pregnancies or miscarriages that might increase my chance of having platelet antibodies?
- •How severe is my typical bleeding history (e.g., heavy periods, nosebleeds), and how might that affect my anxiety and preparation for childbirth?
- •Do I live close enough to a major tertiary care hospital to manage emergency bleeding during my pregnancy?
- •Has my partner been tested to see if they are a carrier for Glanzmann Thrombasthenia?
References
References (22)
- 1
Obstetric and Gynaecological Challenges and Outcomes in Women and Girls With Glanzmann's Thrombasthenia.
Obeng-Tuudah D, Tarawah A, Ozkan M, Abdul-Kadir R
Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(3)):509-518 doi:10.1111/hae.70030.
PMID: 40123272 - 2
Management of pregnancy and childbirth in Glanzmann thrombasthenia: A case series and review.
Rutten KHG, Tsiamita O, Van Thillo Q, et al.
British journal of haematology 2025; (207(4)):1702-1708 doi:10.1111/bjh.70056.
PMID: 40916224 - 3
Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.
Mathews N, Rivard GE, Bonnefoy A
Journal of blood medicine 2021; (12()):449-463 doi:10.2147/JBM.S271744.
PMID: 34149292 - 4
From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia.
Barg AA, Hauschner H, Luboshitz J, et al.
Pediatric blood & cancer 2018; (65(12)):e27376 doi:10.1002/pbc.27376.
PMID: 30216638 - 5
International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD).
Rutten KHG, Schutgens REG, d'Oiron R, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2026; (32(2)):554-560 doi:10.1111/hae.70186.
PMID: 41403382 - 6
How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults.
Grainger JD, Thachil J, Will AM
British journal of haematology 2018; (182(5)):621-632 doi:10.1111/bjh.15409.
PMID: 30117143 - 7
Glanzmann thrombasthenia: genetic basis and clinical correlates.
Botero JP, Lee K, Branchford BR, et al.
Haematologica 2020; (105(4)):888-894 doi:10.3324/haematol.2018.214239.
PMID: 32139434 - 8
Perioperative Platelet Transfusion Strategies and Multidisciplinary Collaboration Experience in Glanzmann Thrombasthenia Caused by ITGA2B Gene Variation During Pregnancy: A Case Report.
Cui X, Ji N, Wang S, et al.
International journal of women's health 2025; (17()):4559-4564 doi:10.2147/IJWH.S548705.
PMID: 41281951 - 9
Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review.
Saultier P, Grino M, Falaise C, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(1)):7-15 doi:10.1111/hae.15130.
PMID: 39604156 - 10
The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Poon MC, d'Oiron R, Zotz RB, et al.
Haematologica 2015; (100(8)):1038-44 doi:10.3324/haematol.2014.121384.
PMID: 26001792 - 11
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes.
Zotz RB, Poon MC, Di Minno G, et al.
TH open : companion journal to thrombosis and haemostasis 2019; (3(3)):e286-e294 doi:10.1055/s-0039-1696657.
PMID: 31523745 - 12
Two case reports of Glanzmann thrombasthenia with intracranial hemorrhage and a review of the literature.
Almesedin GS, Alshmaily HO, Alshammari KA, Albalawi RS
Surgical neurology international 2023; (14()):448 doi:10.25259/SNI_680_2023.
PMID: 38213436 - 13
Lessons Learned: Deformity Correction and Tibiotalocalcaneal Arthrodesis in a Patient With Glanzmann Thrombasthenia: A Case Report.
Lam K, Janney C, Panchbhavi V
JBJS case connector 2020; (10(1)):e0277 doi:10.2106/JBJS.CC.19.00277.
PMID: 32044772 - 14
Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.
Lee SM, Kim KN, Kim SY
Acta haematologica 2019; (142(4)):244-248 doi:10.1159/000499362.
PMID: 31085914 - 15
Unique case of successful surgical treatment of recurrent spinal epidural hematoma after lumbar disc surgery in a Glanzmann thrombasthenia patient.
Al Barbarawi MM, Allouh MZ, Audat ZA, et al.
British journal of neurosurgery 2023; (37(4)):853-855 doi:10.1080/02688697.2019.1678736.
PMID: 31621418 - 16
Fetal and neonatal alloimmune thrombocytopenia.
Zdravic D, Yougbare I, Vadasz B, et al.
Seminars in fetal & neonatal medicine 2016; (21(1)):19-27.
PMID: 26810319 - 17
Imaging and management of fetuses and neonates with alloimmune thrombocytopenia.
Kovanlikaya A, Tiwari P, Bussel JB
Pediatric blood & cancer 2017; (64(12)) doi:10.1002/pbc.26690.
PMID: 28675682 - 18
Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.
Winkelhorst D, Oepkes D, Lopriore E
Expert review of hematology 2017; (10(8)):729-737 doi:10.1080/17474086.2017.1346471.
PMID: 28644735 - 19
Postnatal intervention for the treatment of FNAIT: a systematic review.
Baker JM, Shehata N, Bussel J, et al.
Journal of perinatology : official journal of the California Perinatal Association 2019; (39(10)):1329-1339 doi:10.1038/s41372-019-0360-7.
PMID: 30971767 - 20
Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report.
Enciso L, Aragón-Mendoza RL, León LA, Torres-Torres CG
Cureus 2022; (14(2)):e22570 doi:10.7759/cureus.22570.
PMID: 35355542 - 21
Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia.
Wang Z, Xu Y, Sun Y, et al.
Frontiers in pediatrics 2022; (10()):1062900 doi:10.3389/fped.2022.1062900.
PMID: 36704147 - 22
Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.
Aloui C, Chakroun T, Granados V, et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(8)):689-696 doi:10.1097/MBC.0000000000000779.
PMID: 30325339
This page is for informational purposes only and does not replace professional medical advice. Always consult your maternal-fetal medicine specialist and hematologist regarding pregnancy planning and severe bleeding risks.
Get notified when new evidence is published on Glanzmann Thrombasthenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.